In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora
Enregistré dans:
Auteurs principaux: | Stefan Winkler, Manuel Kussmann, Markus Obermueller, Kathrin Spettel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5008715c0f044f6ea0a9c3e83c898f43 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
par: Helene Broch Tenstad, et autres
Publié: (2021) -
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
par: Gia Deyab, et autres
Publié: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
par: Anne Mirjam Kerola, et autres
Publié: (2021) -
Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
par: Kingsley GH, et autres
Publié: (2015) -
Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
par: Orme ME, et autres
Publié: (2012)